MMP-9 plays an important role in pancreatic cell carcinoma (Coleman et al., 2013), and the PEG-based nanovesicles of MMP-9 represent a potential new option for radical treatment of pancreatic cancer. This evidence concerns the gene MMP9 and familial pancreatic carcinoma.